Since the altered NPTX2 levels precede AD clinical symptoms and NPTX2 is detected with a synaptic degeneration marker rather than an AD-specific marker, the level of NPTX2 may be used as a prediction marker with broad applicability. Here, NPTX2 is linked to Alzheimer disease.